Page last updated: 2024-10-20

urea and Bronchopulmonary Dysplasia

urea has been researched along with Bronchopulmonary Dysplasia in 7 studies

pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.

Bronchopulmonary Dysplasia: A chronic lung disease developed after OXYGEN INHALATION THERAPY or mechanical ventilation (VENTILATION, MECHANICAL) usually occurring in certain premature infants (INFANT, PREMATURE) or newborn infants with respiratory distress syndrome (RESPIRATORY DISTRESS SYNDROME, NEWBORN). Histologically, it is characterized by the unusual abnormalities of the bronchioles, such as METAPLASIA, decrease in alveolar number, and formation of CYSTS.

Research Excerpts

ExcerptRelevanceReference
"Most babies treated with dexamethasone for bronchopulmonary dysplasia exhibit an appreciable rise in the blood urea concentration, from a mean of 2."3.68Catabolic effect of dexamethasone in the preterm baby. ( Brownlee, KG; Dear, PR; Green, JH; Henderson, MJ; Ng, PC; Smith, M, 1992)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (42.86)18.2507
2000's2 (28.57)29.6817
2010's1 (14.29)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Course, CW1
Lewis, PA1
Kotecha, SJ1
Cousins, M1
Hart, K1
Heesom, KJ1
Watkins, WJ1
Kotecha, S1
Trittmann, JK1
Jin, Y1
Chicoine, LG1
Liu, Y1
Chen, B1
Nelin, LD1
D'Angio, CT1
Basavegowda, K1
Avissar, NE1
Finkelstein, JN1
Sinkin, RA1
Capoluongo, E1
Ameglio, F1
Lulli, P1
Minucci, A1
Santonocito, C1
Concolino, P1
Di Stasio, E1
Boccacci, S1
Vendettuoli, V1
Giuratrabocchetta, G1
De Cunto, A1
Tana, M1
Romagnoli, C1
Zuppi, C1
Vento, G1
Boehm, G1
Bierbach, U1
Moro, G1
Minoli, I1
Brownlee, KG1
Ng, PC1
Henderson, MJ1
Smith, M1
Green, JH1
Dear, PR1
Williams, AF1
Jones, M1

Trials

2 trials available for urea and Bronchopulmonary Dysplasia

ArticleYear
Comparison of tracheal aspirate and bronchoalveolar lavage specimens from premature infants.
    Biology of the neonate, 2002, Volume: 82, Issue:3

    Topics: Body Fluids; Bronchoalveolar Lavage Fluid; Bronchopulmonary Dysplasia; Dexamethasone; Double-Blind M

2002
Epithelial lining fluid free IGF-I-to-PAPP-A ratio is associated with bronchopulmonary dysplasia in preterm infants.
    American journal of physiology. Endocrinology and metabolism, 2007, Volume: 292, Issue:1

    Topics: Bronchoalveolar Lavage Fluid; Bronchopulmonary Dysplasia; Humans; Infant, Newborn; Infant, Premature

2007

Other Studies

5 other studies available for urea and Bronchopulmonary Dysplasia

ArticleYear
Evidence of abnormality in glutathione metabolism in the airways of preterm born children with a history of bronchopulmonary dysplasia.
    Scientific reports, 2023, 11-09, Volume: 13, Issue:1

    Topics: Alanine; Bronchopulmonary Dysplasia; Child; Glutathione; Humans; Infant, Newborn; Lung; Urea

2023
An arginase-1 SNP that protects against the development of pulmonary hypertension in bronchopulmonary dysplasia enhances NO-mediated apoptosis in lymphocytes.
    Physiological reports, 2016, Volume: 4, Issue:22

    Topics: Apoptosis; Arginase; Arginine; Bronchopulmonary Dysplasia; Caspase 3; Cohort Studies; Humans; Hypert

2016
Limited fat digestion in infants with bronchopulmonary dysplasia.
    Journal of pediatric gastroenterology and nutrition, 1996, Volume: 22, Issue:2

    Topics: Bile Acids and Salts; Bronchopulmonary Dysplasia; Dietary Fats; Duodenum; Feces; Female; Humans; Hya

1996
Catabolic effect of dexamethasone in the preterm baby.
    Archives of disease in childhood, 1992, Volume: 67, Issue:1 Spec No

    Topics: Bronchopulmonary Dysplasia; Creatine; Creatinine; Dexamethasone; Humans; Infant, Newborn; Infant, Pr

1992
Dexamethasone increases plasma amino acid concentrations in bronchopulmonary dysplasia.
    Archives of disease in childhood, 1992, Volume: 67, Issue:1 Spec No

    Topics: Amino Acids; Bronchopulmonary Dysplasia; Dexamethasone; Humans; Infant, Low Birth Weight; Infant, Ne

1992